<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="translate">
<roleset id="translate.01" name="molecular event of producing genetic product called protein
" wordnet="10">
<roles>
  <role n="1" descr="resultant product 			// protein //
"/>
  <role n="2" descr="source 					// mRNA, transcript // 
"/>
  <role n="3" descr="location as tissue, cell, vitro
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
Alternative splicing of exon 4 results in a transcript which would be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the ET-AR protein. 

</text>
       <arg n="1">[into] a C-terminal truncated protein containing the first, second and third transmembrane domains
</arg>
       <arg n="2">a transcript
</arg>
       <arg n="3">-
</arg>
<fdg>
1	Alternative	alternative	attr:&gt;2	@A&gt; %&gt;N N NOM SG	@A&gt; %&gt;N A ABS
2	splicing	splicing		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@PCOMPL-S %NH N NOM SG
3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
4	exon	exon	pcomp:&gt;3	@&lt;P %NH N NOM SG
5	4	4	qn:&gt;6	@QN&gt; %&gt;N NUM CARD
6	results	result		@NH %NH N NOM PL	@SUBJ %NH N NOM PL
7	in	in	mod:&gt;6	@&lt;NOM %N&lt; PREP
8	a	a	det:&gt;9	@DN&gt; %&gt;N DET SG
9	transcript	transcript	pcomp:&gt;7	@&lt;P %NH N NOM SG
10	which	which	subj:&gt;11	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
11	would	would	v-ch:&gt;12	@+FAUXV %AUX V AUXMOD
12	be	be	v-ch:&gt;13	@-FAUXV %AUX V INF
13	translated	translate	mod:&gt;9	@-FMAINV %VP EN
14	into	into	goa:&gt;13	@ADVL %EH PREP
15	a	a	det:&gt;18	@DN&gt; %&gt;N DET SG
16	C-terminal	c-terminal	attr:&gt;17	@A&gt; %&gt;N A ABS
17	truncated	truncated	attr:&gt;18	@A&gt; %&gt;N A ABS
18	protein	protein	pcomp:&gt;14	@&lt;P %NH N NOM SG
19	containing	contain	mod:&gt;18	@-FMAINV %VA ING
20	the	the	det:&gt;21	@DN&gt; %&gt;N DET
21	first	first		@ADVL %EH NUM ORD
22	,	,
23	second	second		@A&gt; %&gt;N NUM ORD	@PCOMPL-S %NH NUM ORD	@SUBJ %NH NUM ORD	@OBJ %NH NUM ORD	

@ADVL %EH NUM ORD	@&lt;P %NH NUM ORD	@&lt;NOM %N&lt; NUM ORD
24	and	and		@CC %CC CC
25	third	third	attr:&gt;26	@A&gt; %&gt;N NUM ORD
26	transmembrane	transmembrane	attr:&gt;27	@A&gt; %&gt;N &lt;?&gt; N NOM SG
27	domains	domain		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL	@APP %NH N 

NOM PL	@&lt;P %NH N NOM PL
28	,	,
29	while	while	tmp:&gt;38	@ADVL %EH ADV WH
30	the	the	det:&gt;31	@DN&gt; %&gt;N DET
31	splicing	splicing	subj:&gt;37	@SUBJ %NH A ABS
32	out of	out of	mod:&gt;31	@&lt;NOM %N&lt; PREP
33	exons	exon	pcomp:&gt;32	@&lt;P %NH &lt;?&gt; N NOM PL
34	3	3	mod:&gt;33	@&lt;NOM %N&lt; NUM CARD
35	and	and	cc:&gt;34	@CC %CC CC
36	4	4	cc:&gt;34	@&lt;NOM %N&lt; NUM CARD
37	would	would	v-ch:&gt;38	@+FAUXV %AUX V AUXMOD
38	produce	produce	tmp:&gt;19	@-FMAINV %VA V INF
39	a	a	det:&gt;40	@DN&gt; %&gt;N DET SG
40	protein	protein	obj:&gt;38	@OBJ %NH N NOM SG
41	with	with	ins:&gt;38	@ADVL %EH PREP
42	five	five	qn:&gt;44	@QN&gt; %&gt;N NUM CARD
43	membrane-spanning	membrane-spanning	attr:&gt;44	@A&gt; %&gt;N &lt;?&gt; A ABS
44	domains	domain	pcomp:&gt;41	@&lt;P %NH N NOM PL
45	but	but		@CC %CC CC
46	lacking	lack		@&lt;P-FMAINV %VA ING	@-FMAINV %VA ING
47	the	the	det:&gt;51	@DN&gt; %&gt;N DET
48	third	third	cc:&gt;50	@A&gt; %&gt;N NUM ORD
49	and	and	cc:&gt;50	@CC %CC CC
50	fourth	fourth	attr:&gt;51	@A&gt; %&gt;N NUM ORD
51	domains	domain		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL
52	present	present		@-FMAINV %VA V INF	@&lt;P-FMAINV %VA V INF	@PCOMPL-S %NH A ABS	@&lt;NOM %N&lt; A 

ABS
53	in	in		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
54	the	the	det:&gt;56	@DN&gt; %&gt;N DET
55	ET-AR	et-ar	attr:&gt;56	@A&gt; %&gt;N N NOM SG
56	protein	protein	pcomp:&gt;53	@&lt;P %NH N NOM SG
57	.     .
</fdg>
</example>
<example src="EMBO" no="1">
<text>
Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 were translated in vitro and partially purified on heparin-agarose.

</text>
       <arg n="1">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1
</arg>
       <arg n="2">-
</arg>
       <arg n="3">[in] vitro
</arg>
<fdg>
1	Stat1	stat1	cc:&gt;4	@SUBJ %NH N NOM SG
2	,	,
3	Stat1	stat1	attr:&gt;4	@A&gt; %&gt;N N NOM SG
4	Y701F	y701f	cc:&gt;7	@SUBJ %NH NUM CARD
5	,	,
6	Stat1	stat1	attr:&gt;7	@A&gt; %&gt;N N NOM SG
7	N135	n135	cc:&gt;10	@SUBJ %NH N NOM SG
8	,	,
9	Stat1	stat1	attr:&gt;10	@A&gt; %&gt;N N NOM SG
10	N200	n200	cc:&gt;12	@SUBJ %NH N NOM SG
11	and	and	cc:&gt;12	@CC %CC CC
12	Stat5/1	stat5/1	subj:&gt;13	@SUBJ %NH &lt;?&gt; NUM CARD
13	were	be	v-ch:&gt;14	@+FAUXV %AUX V PAST PL
14	translated	translate	main:&gt;0	@-FMAINV %VP EN
15	in vitro	in vitro		@ADVL %EH ADV	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
16	and	and	cc:&gt;14	@CC %CC CC
17	partially	partially	man:&gt;18	@ADVL %EH ADV
18	purified	purify	cc:&gt;14	@-FMAINV %VP EN
19	on	on	ha:&gt;18	@ADVL %EH PREP
20	heparin	heparin	pcomp:&gt;19	@&lt;P %NH &lt;?&gt; N NOM SG
21	-	-
22	agarose	agarose	obj:&gt;18	@OBJ %NH &lt;?&gt; N NOM SG
23	.     .
</fdg>
</example>
<example src="EMBO" no="2">
<text>
Stat1 Y701F translated in vitro can also dimerize on the LMP2 GAS.

</text>
       <arg n="1">Stat1 Y701F
</arg>
       <arg n="2">-
</arg>
       <arg n="3">[in] vitro
</arg>
<fdg>
1	Stat1	stat1		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@A&gt; %&gt;N N NOM SG
2	Y701F	y701f		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
3	translated	translate		@-FMAINV %VP EN
4	in vitro	in vitro	ha:&gt;3	@ADVL %EH ADV
5	can	can	v-ch:&gt;7	@+FAUXV %AUX V AUXMOD
6	also	also	meta:&gt;7	@ADVL %EH ADV
7	dimerize	dimerize		@-FMAINV %VA V INF
8	on	on	ha:&gt;7	@ADVL %EH PREP
9	the	the	det:&gt;11	@DN&gt; %&gt;N DET
10	LMP2	lmp2	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	GAS	gas	pcomp:&gt;8	@&lt;P %NH N NOM SG
12	.     .
</fdg>
</example>
<example src="EMBO" no="3">
<text>
In vitro translation and partial purification o fStat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 were translated in vitro using the T7-based coupled transcription-translation kit (Promega) as per the manufacturer fs instructions.

</text>
       <arg n="1">Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1
</arg>
       <arg n="2">-
</arg>
       <arg n="3">[in] vitro
</arg>
<fdg>

1	In vitro	in vitro	attr:&gt;2	@A&gt; %&gt;N A ABS
2	translation	translation	cc:&gt;5	@SUBJ %NH N NOM SG
3	and	and	cc:&gt;5	@CC %CC CC
4	partial	partial	attr:&gt;5	@A&gt; %&gt;N A ABS
5	purification	purification	subj:&gt;20	@SUBJ %NH N NOM SG
6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
7	Stat1	stat1	attr:&gt;8	@A&gt; %&gt;N N NOM SG
8	Stat1	stat1	pcomp:&gt;6	@&lt;P %NH N NOM SG
9	,	,
10	Stat1	stat1	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	Y701F	y701f	cc:&gt;8	@&lt;P %NH NUM CARD
12	,	,
13	Stat1	stat1	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	N135	n135	cc:&gt;11	@&lt;P %NH N NOM SG
15	,	,
16	Stat1	stat1	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	N200	n200	cc:&gt;14	@&lt;P %NH N NOM SG
18	and	and	cc:&gt;17	@CC %CC CC
19	Stat5/1	stat5/1	cc:&gt;17	@&lt;P %NH &lt;?&gt; NUM CARD
20	were	be	v-ch:&gt;21	@+FAUXV %AUX V PAST PL
21	translated	translate	main:&gt;0	@-FMAINV %VP EN
22	in vitro	in vitro		@ADVL %EH ADV	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
23	using	use		@-FMAINV %VA ING
24	the	the	det:&gt;28	@DN&gt; %&gt;N DET
25	T7-based	t7-based	attr:&gt;26	@A&gt; %&gt;N &lt;?&gt; A ABS
26	coupled	coupled	attr:&gt;27	@A&gt; %&gt;N A ABS
27	transcription-translation	transcription-translation	attr:&gt;28	@A&gt; %&gt;N &lt;?&gt; N NOM SG
28	kit	kit	obj:&gt;23	@OBJ %NH N NOM SG
29	(	(
30	Promega	promega	mod:&gt;28	@NH %NH &lt;?&gt; N NOM SG
31	)	)
32	as per	as per	ha:&gt;23	@ADVL %EH PREP
33	the	the	det:&gt;36	@DN&gt; %&gt;N DET
34	manufacturer	manufacturer	attr:&gt;35	@A&gt; %&gt;N N NOM SG
35	fs	f	attr:&gt;36	@A&gt; %&gt;N &lt;?&gt; N NOM PL
36	instructions	instruction	pcomp:&gt;32	@&lt;P %NH N NOM PL
37	.     .
</fdg>
</example>
<example src="EMBO" no="4">
<text>
We also report the first definitive incorporation of Sec into a selenoprotein translated in reticulocyte lysates.

</text>
       <arg n="1">a selenoprotein
</arg>
       <arg n="2">-
</arg>
       <arg n="3">[in] reticulocyte lysates
</arg>
<fdg>
1	We	we	subj:&gt;3	@SUBJ %NH PRON PERS NOM PL1
2	also	also	meta:&gt;3	@ADVL %EH ADV
3	report	report	main:&gt;0	@+FMAINV %VA V PRES
4	the	the	det:&gt;7	@DN&gt; %&gt;N DET
5	first	first	attr:&gt;6	@A&gt; %&gt;N NUM ORD
6	definitive	definitive	attr:&gt;7	@A&gt; %&gt;N A ABS
7	incorporation	incorporation	obj:&gt;3	@OBJ %NH N NOM SG
8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
9	Sec	sec	pcomp:&gt;8	@&lt;P %NH ABBR NOM SG
10	into	into	goa:&gt;3	@ADVL %EH PREP
11	a	a	det:&gt;12	@DN&gt; %&gt;N DET SG
12	selenoprotein	selenoprotein	pcomp:&gt;10	@&lt;P %NH &lt;?&gt; N NOM SG
13	translated	translate	mod:&gt;12	@-FMAINV %VP EN
14	in	in	ha:&gt;13	@ADVL %EH PREP
15	reticulocyte	reticulocyte	attr:&gt;16	@A&gt; %&gt;N &lt;?&gt; N NOM SG
16	lysates	lysat*	pcomp:&gt;14	@&lt;P %NH &lt;?&gt; N NOM
17	.     .
</fdg>
</example>
<example src="EMBO" no="5">
<text>
This mutant was translated in the presence of C-terminal SBP2, and as shown in Figure 6C no readthrough is detectable when the AUGA element is deleted, indicating that the stimulatory effect is entirely 3 UTR dependent.

</text>
       <arg n="1">This mutant
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
2	mutant	mutant	subj:&gt;3	@SUBJ %NH N NOM SG
3	was	be	v-ch:&gt;4	@+FAUXV %AUX V PAST
4	translated	translate		@-FMAINV %VP EN
5	in	in	man:&gt;4	@ADVL %EH PREP
6	the	the	det:&gt;7	@DN&gt; %&gt;N DET
7	presence	presence	pcomp:&gt;5	@&lt;P %NH N NOM SG
8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
9	C-terminal	c-terminal	attr:&gt;10	@A&gt; %&gt;N A ABS
10	SBP2	sbp2	pcomp:&gt;8	@&lt;P %NH N NOM SG
11	,	,
12	and	and		@CC %CC CC
13	as	as	pm:&gt;14	@CS %CS CS
14	shown	show		@-FMAINV %VP EN
15	in	in	ha:&gt;14	@ADVL %EH PREP
16	Figure	figure	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	6C	6c	qn:&gt;18	@QN&gt; %&gt;N NUM CARD
18	no	no	det:&gt;19	@DN&gt; %&gt;N DET
19	readthrough	readthrough	pcomp:&gt;15	@&lt;P %NH &lt;?&gt; N NOM SG
20	is	be		@+FMAINV %VA V PRES SG3
21	detectable	detectable	comp:&gt;20	@PCOMPL-S %NH A ABS
22	when	when	tmp:&gt;27	@ADVL %EH ADV WH
23	the	the	det:&gt;25	@DN&gt; %&gt;N DET
24	AUGA	auga	attr:&gt;25	@A&gt; %&gt;N N NOM SG
25	element	element	subj:&gt;26	@SUBJ %NH N NOM SG
26	is	be	v-ch:&gt;27	@+FAUXV %AUX V PRES SG3
27	deleted	delete	tmp:&gt;20	@-FMAINV %VP EN
28	,	,
29	indicating	indicate	man:&gt;27	@-FMAINV %VA ING
30	that	that	pm:&gt;34	@CS %CS CS
31	the	the	det:&gt;33	@DN&gt; %&gt;N DET
32	stimulatory	stimulatory	attr:&gt;33	@A&gt; %&gt;N A ABS
33	effect	effect	subj:&gt;34	@SUBJ %NH N NOM SG
34	is	be	obj:&gt;29	@+FMAINV %VA V PRES SG3
35	entirely	entirely	ad:&gt;36	@AD-A&gt; %E&gt; ADV
36	3	3	qn:&gt;38	@QN&gt; %&gt;N NUM CARD
37	&apos;	&apos;
38	UTR	utr	comp:&gt;34	@PCOMPL-S %NH N NOM SG
39	dependent	dependent	mod:&gt;38	@&lt;NOM %N&lt; A ABS
40	.     .
</fdg>
</example>
</roleset>

<roleset id="translate.02" name="changes from one form into another form
" wordnet="2">
<roles>
  <role n="0" descr="agent/ causer mechanism
"/>
  <role n="1" descr="after translation		
"/>
  <role n="2" descr="before translation       		
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
This review examines the use of new and emerging DNA, tissue, and live-cell transfection microarray technologies that can be used to discover, validate, and translate information resulting from the completion of the Human Genome Project.

</text>
       <arg n="0">the use of new and emerging DNA, tissue, and live-cell transfection microarray technologies 
</arg>
       <arg n="1">information resulting from the completion of the Human Genome Project
</arg>
       <arg n="2">-
</arg>
<fdg>
1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
2	review	review	subj:&gt;3	@SUBJ %NH N NOM SG
3	examines	examine		@+FMAINV %VA V PRES SG3
4	the	the	det:&gt;5	@DN&gt; %&gt;N DET
5	use	use	obj:&gt;3	@OBJ %NH N NOM SG
6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
7	new	new	cc:&gt;9	@A&gt; %&gt;N A ABS
8	and	and	cc:&gt;9	@CC %CC CC
9	emerging	emerging	attr:&gt;10	@A&gt; %&gt;N A ABS
10	DNA	dna	pcomp:&gt;6	@&lt;P %NH ABBR NOM SG
11	,	,
12	tissue	tissue	mod:&gt;10	@APP %NH N NOM SG
13	,	,
14	and	and		@CC %CC CC
15	live-cell	live-cell	attr:&gt;16	@A&gt; %&gt;N &lt;?&gt; N NOM SG
16	transfection	transfection	attr:&gt;17	@A&gt; %&gt;N &lt;?&gt; N NOM SG
17	microarray	microarray	attr:&gt;18	@A&gt; %&gt;N &lt;?&gt; N NOM SG
18	technologies	technology		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL	@APP %NH N NOM PL	@&lt;P %NH N NOM PL
19	that	that	subj:&gt;20	@SUBJ %NH &lt;Rel&gt; PRON
20	can	can	v-ch:&gt;21	@+FAUXV %AUX V AUXMOD
21	be	be	v-ch:&gt;22	@-FAUXV %AUX V INF
22	used	use	mod:&gt;18	@-FMAINV %VP EN
23	to	to	pm:&gt;24	@INFMARK&gt; %AUX INFMARK&gt;
24	discover	discover	cnt:&gt;22	@-FMAINV %VA V INF
25	,	,
26	validate	validate	cc:&gt;24	@-FMAINV %VA V INF
27	,	,
28	and	and		@CC %CC CC
29	translate	translate		@+FMAINV %VA V PRES
30	information	information	obj:&gt;29	@OBJ %NH N NOM SG
31	resulting	result	mod:&gt;30	@-FMAINV %VA ING
32	from	from	ha:&gt;31	@ADVL %EH PREP
33	the	the	det:&gt;34	@DN&gt; %&gt;N DET
34	completion	completion	pcomp:&gt;32	@&lt;P %NH N NOM SG
35	of	of	mod:&gt;34	@&lt;NOM-OF %N&lt; PREP
36	the	the	det:&gt;39	@DN&gt; %&gt;N DET
37	Human	human	attr:&gt;38	@A&gt; %&gt;N A ABS
38	Genome	genome	attr:&gt;39	@A&gt; %&gt;N N NOM SG
39	Project	project	pcomp:&gt;35	@&lt;P %NH N NOM SG
40	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
Malaria is an attractive model for the development and validation of approaches to translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions and because the Plasmodium parasite is a complex multistage pathogen targeted by multiple immune responses.

</text>
       <arg n="0">-
</arg>
       <arg n="1">[to] vaccine development
</arg>
       <arg n="2">genomic information 
</arg>
<fdg>
1	Malaria	malaria	subj:&gt;2	@SUBJ %NH N NOM SG
2	is	be		@+FMAINV %VA V PRES SG3
3	an	an	det:&gt;5	@DN&gt; %&gt;N DET SG
4	attractive	attractive	attr:&gt;5	@A&gt; %&gt;N A ABS
5	model	model	comp:&gt;2	@PCOMPL-S %NH N NOM SG
6	for	for	mod:&gt;5	@&lt;NOM %N&lt; PREP
7	the	the	det:&gt;8	@DN&gt; %&gt;N DET
8	development	development	pcomp:&gt;6	@&lt;P %NH N NOM SG
9	and	and	cc:&gt;8	@CC %CC CC
10	validation	validation	cc:&gt;8	@&lt;P %NH N NOM SG
11	of	of	mod:&gt;10	@&lt;NOM-OF %N&lt; PREP
12	approaches	approach	pcomp:&gt;11	@&lt;P %NH N NOM PL
13	to	to	pm:&gt;14	@INFMARK&gt; %AUX INFMARK&gt;
14	translate	translate	mod:&gt;12	@-FMAINV %VA V INF
15	genomic	genomic	attr:&gt;16	@A&gt; %&gt;N A ABS
16	information	information	obj:&gt;14	@OBJ %NH N NOM SG
17	to	to	goa:&gt;14	@ADVL %EH PREP
18	vaccine	vaccine	attr:&gt;19	@A&gt; %&gt;N N NOM SG
19	development	development	pcomp:&gt;17	@&lt;P %NH N NOM SG
20	because of	because of	mod:&gt;19	@&lt;NOM %N&lt; PREP
21	the	the	det:&gt;23	@DN&gt; %&gt;N DET
22	critical	critical	attr:&gt;23	@A&gt; %&gt;N A ABS
23	need	need	pcomp:&gt;20	@&lt;P %NH N NOM SG
24	for	for	mod:&gt;23	@&lt;NOM %N&lt; PREP
25	effective	effective	attr:&gt;26	@A&gt; %&gt;N A ABS
26	anti-malarial	anti-malarial	attr:&gt;27	@A&gt; %&gt;N A ABS
27	interventions	intervention	pcomp:&gt;24	@&lt;P %NH N NOM PL
28	and	and		@CC %CC CC
29	because	because	pm:&gt;33	@CS %CS CS
30	the	the	det:&gt;32	@DN&gt; %&gt;N DET
31	Plasmodium	plasmodium	attr:&gt;32	@A&gt; %&gt;N N NOM SG
32	parasite	parasite	subj:&gt;33	@SUBJ %NH N NOM SG
33	is	be		@+FMAINV %VA V PRES SG3
34	a	a	det:&gt;37	@DN&gt; %&gt;N DET SG
35	complex	complex	attr:&gt;36	@A&gt; %&gt;N A ABS
36	multistage	multistage	attr:&gt;37	@A&gt; %&gt;N A ABS
37	pathogen	pathogen	comp:&gt;33	@PCOMPL-S %NH N NOM SG
38	targeted	target	mod:&gt;37	@-FMAINV %VP EN
39	by	by	ha:&gt;38	@ADVL %EH PREP
40	multiple	multiple	attr:&gt;41	@A&gt; %&gt;N A ABS
41	immune	immune	attr:&gt;42	@A&gt; %&gt;N A ABS
42	responses	response	pcomp:&gt;39	@&lt;P %NH N NOM PL
43	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
Thus, Acj6 and Drifter translate PN lineage information into distinct dendritic targeting specificity.

</text>
       <arg n="0">Acj6 and Drifter
</arg>
       <arg n="1">[into] distinct dendritic targeting specificity
</arg>
       <arg n="2">PN lineage information 
</arg>
<fdg>
1	Thus	thus	meta:&gt;6	@ADVL %EH ADV
2	,	,
3	Acj6	acj6	cc:&gt;5	@SUBJ %NH N NOM SG
4	and	and	cc:&gt;5	@CC %CC CC
5	Drifter	drifter	subj:&gt;6	@SUBJ %NH N NOM SG
6	translate	translate	main:&gt;0	@+FMAINV %VA V PRES
7	PN	pn	attr:&gt;8	@A&gt; %&gt;N ABBR NOM SG
8	lineage	lineage	attr:&gt;9	@A&gt; %&gt;N N NOM SG
9	information	information	obj:&gt;6	@OBJ %NH N NOM SG
10	into	into	goa:&gt;6	@ADVL %EH PREP
11	distinct	distinct	attr:&gt;12	@A&gt; %&gt;N A ABS
12	dendritic	dendritic	attr:&gt;13	@A&gt; %&gt;N A ABS
13	targeting	targeting	attr:&gt;14	@A&gt; %&gt;N A ABS
14	specificity	specificity	pcomp:&gt;10	@&lt;P %NH N NOM SG
15	.     .
</fdg>
</example>
<example src="MEDLINE" no="4">
<text>
Cells use signalling networks to translate with high fidelity extracellular signals into specific cellular functions.

</text>
       <arg n="0">Cells
</arg>
       <arg n="1">[into] specific cellular functions
</arg>
       <arg n="2">extracellular signals 
</arg>
<fdg>
1	Cells	cell	subj:&gt;2	@SUBJ %NH N NOM PL
2	use	use	main:&gt;0	@+FMAINV %VA V PRES
3	signalling	signalling	attr:&gt;4	@A&gt; %&gt;N A ABS
4	networks	network	obj:&gt;2	@OBJ %NH N NOM PL
5	to	to	pm:&gt;6	@INFMARK&gt; %AUX INFMARK&gt;
6	translate	translate	mod:&gt;4	@-FMAINV %VA V INF
7	with	with	ha:&gt;6	@ADVL %EH PREP
8	high	high	attr:&gt;9	@A&gt; %&gt;N A ABS
9	fidelity	fidelity	pcomp:&gt;7	@&lt;P %NH N NOM SG
10	extracellular	extracellular	attr:&gt;11	@A&gt; %&gt;N A ABS
11	signals	signal	obj:&gt;6	@OBJ %NH N NOM PL
12	into	into	goa:&gt;6	@ADVL %EH PREP
13	specific	specific	attr:&gt;14	@A&gt; %&gt;N A ABS
14	cellular	cellular	attr:&gt;15	@A&gt; %&gt;N A ABS
15	functions	function	pcomp:&gt;12	@&lt;P %NH N NOM PL
16	.     .
</fdg>
</example>
</roleset>

<roleset id="translate.03" name="translate into = be equivalent in effect
" wordnet="6">
<roles>
  <role n="1" descr="theme
"/>
  <role n="2" descr="equivalence       		
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
In addition, our data show that the functions performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis translate into complex, differential modulations of individual Bcl-2 homologs.

</text>
       <arg n="1">complex, differential modulations of individual Bcl-2 homologs
</arg>
       <arg n="2">the functions
</arg>
<fdg>
1	In	in	cla:&gt;6	@ADVL %EH PREP
2	addition	addition	pcomp:&gt;1	@&lt;P %NH N NOM SG
3	,	,
4	our	we	attr:&gt;5	@A&gt; %&gt;N PRON PERS GEN PL1
5	data	data	subj:&gt;6	@SUBJ %NH N NOM
6	show	show	main:&gt;0	@+FMAINV %VA V PRES
7	that	that		@CS %CS CS
8	the	the	det:&gt;9	@DN&gt; %&gt;N DET
9	functions	function		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@I-OBJ %NH N NOM PL
10	performed	perform	mod:&gt;9	@-FMAINV %VP EN
11	by	by	ha:&gt;10	@ADVL %EH PREP
12	these	this	det:&gt;13	@DN&gt; %&gt;N DET DEM PL
13	molecules/pathways	molecules/pathway	pcomp:&gt;11	@&lt;P %NH &lt;?&gt; N NOM PL
14	in	in		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
15	promoting	promote	pcomp:&gt;14	@&lt;P-FMAINV %VA ING
16	cell	cell	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	survival	survival	obj:&gt;15	@OBJ %NH N NOM SG
18	or	or		@CC %CC CC
19	apoptosis/anoikis	apoptosis/anoiki	subj:&gt;20	@SUBJ %NH &lt;?&gt; N NOM PL
20	translate	translate		@+FMAINV %VA V PRES
21	into	into	ha:&gt;20	@ADVL %EH PREP
22	complex	complex	cc:&gt;24	@A&gt; %&gt;N A ABS
23	,	,
24	differential	differential	attr:&gt;25	@A&gt; %&gt;N A ABS
25	modulations	modulation	pcomp:&gt;21	@&lt;P %NH N NOM PL
26	of	of	mod:&gt;25	@&lt;NOM-OF %N&lt; PREP
27	individual	individual	attr:&gt;28	@A&gt; %&gt;N A ABS
28	Bcl-2	bcl-2	qn:&gt;29	@QN&gt; %&gt;N &lt;?&gt; NUM CARD
29	homologs	homolog	pcomp:&gt;26	@&lt;P %NH N NOM PL
30	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
This may translate into faster activation of the muscle fibres, thus partly explaining the increase in power output.

</text>
       <arg n="1">faster activation of the muscle fibres 
</arg>
       <arg n="2">This
</arg>
<fdg>
1	This	this	subj:&gt;2	@SUBJ %NH PRON DEM SG
2	may	may	v-ch:&gt;3	@+FAUXV %AUX V AUXMOD
3	translate	translate	main:&gt;0	@-FMAINV %VA V INF
4	into	into	goa:&gt;3	@ADVL %EH PREP
5	faster	fast	attr:&gt;6	@A&gt; %&gt;N A CMP
6	activation	activation	pcomp:&gt;4	@&lt;P %NH N NOM SG
7	of	of	mod:&gt;6	@&lt;NOM-OF %N&lt; PREP
8	the	the	det:&gt;10	@DN&gt; %&gt;N DET
9	muscle	muscle	attr:&gt;10	@A&gt; %&gt;N N NOM SG
10	fibres	fibre	pcomp:&gt;7	@&lt;P %NH N NOM PL
11	,	,
12	thus	thus	meta:&gt;14	@ADVL %EH ADV
13	partly	partly		@ADVL %EH ADV
14	explaining	explain		@-FMAINV %VA ING
15	the	the	det:&gt;16	@DN&gt; %&gt;N DET
16	increase	increase	obj:&gt;14	@OBJ %NH N NOM SG
17	in	in	mod:&gt;16	@&lt;NOM %N&lt; PREP
18	power	power	attr:&gt;19	@A&gt; %&gt;N N NOM SG
19	output	output	pcomp:&gt;17	@&lt;P %NH N NOM SG
20	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
Persistent diuretic use results in dynamic changes in ECW and other body fluid compartments that translate into chronic blood pressure reduction.

</text>
       <arg n="1">chronic blood pressure reduction 
</arg>
       <arg n="2">dynamic changes in ECW and other body fluid compartments 
</arg>
<fdg>
1	Persistent	persistent	attr:&gt;2	@A&gt; %&gt;N A ABS
2	diuretic	diuretic	attr:&gt;3	@A&gt; %&gt;N A ABS
3	use	use	subj:&gt;4	@SUBJ %NH N NOM SG
4	results	result	main:&gt;0	@+FMAINV %VA V PRES SG3
5	in	in	loc:&gt;4	@ADVL %EH PREP
6	dynamic	dynamic	attr:&gt;7	@A&gt; %&gt;N A ABS
7	changes	change	pcomp:&gt;5	@&lt;P %NH N NOM PL
8	in	in	phr:&gt;4	@ADVL %EH PREP
9	ECW	ecw	pcomp:&gt;8	@&lt;P %NH N NOM SG
10	and	and	cc:&gt;9	@CC %CC CC
11	other	other	det:&gt;14	@DN&gt; %&gt;N DET
12	body	body	attr:&gt;13	@A&gt; %&gt;N N NOM SG
13	fluid	fluid	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	compartments	compartment	cc:&gt;9	@&lt;P %NH N NOM PL
15	that	that	subj:&gt;16	@SUBJ %NH &lt;Rel&gt; PRON
16	translate	translate	mod:&gt;14	@+FMAINV %VA V PRES
17	into	into	goa:&gt;16	@ADVL %EH PREP
18	chronic	chronic	attr:&gt;19	@A&gt; %&gt;N A ABS
19	blood	blood	attr:&gt;20	@A&gt; %&gt;N N NOM SG
20	pressure	pressure	attr:&gt;21	@A&gt; %&gt;N N NOM SG
21	reduction	reduction	pcomp:&gt;17	@&lt;P %NH N NOM SG
22	.     .
</fdg>
</example>
<example src="MEDLINE" no="4">
<text>
The simple rules governing how local interactions among individuals translate into group behaviors are found across social groups, giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution.

</text>
       <arg n="1">group behaviors 
</arg>
       <arg n="2">local interactions among individuals 
</arg>
<fdg>
1	The	the	det:&gt;3	@DN&gt; %&gt;N DET
2	simple	simple	attr:&gt;3	@A&gt; %&gt;N A ABS
3	rules	rule		@NH %NH N NOM PL	@SUBJ %NH N NOM PL	@PCOMPL-S %NH N NOM PL
4	governing	govern		@-FMAINV %VA ING
5	how	how	man:&gt;10	@ADVL %EH ADV WH
6	local	local	attr:&gt;7	@A&gt; %&gt;N A ABS
7	interactions	interaction	subj:&gt;10	@SUBJ %NH N NOM PL
8	among	among	mod:&gt;7	@&lt;NOM %N&lt; PREP
9	individuals	individual	pcomp:&gt;8	@&lt;P %NH N NOM PL
10	translate	translate	obj:&gt;4	@+FMAINV %VA V PRES
11	into	into	goa:&gt;10	@ADVL %EH PREP
12	group	group	attr:&gt;13	@A&gt; %&gt;N N NOM
13	behaviors	behavior	pcomp:&gt;11	@&lt;P %NH N NOM PL
14	are	be	v-ch:&gt;15	@+FAUXV %AUX V PRES
15	found	find		@-FMAINV %VP EN
16	across	across	ha:&gt;15	@ADVL %EH PREP
17	social	social	attr:&gt;18	@A&gt; %&gt;N A ABS
18	groups	group	pcomp:&gt;16	@&lt;P %NH N NOM PL
19	,	,
20	giving	give	man:&gt;15	@-FMAINV %VA ING
21	social	social	attr:&gt;22	@A&gt; %&gt;N A ABS
22	insects	insect	dat:&gt;20	@I-OBJ %NH N NOM PL
23	the	the	det:&gt;24	@DN&gt; %&gt;N DET
24	potential	potential	obj:&gt;20	@OBJ %NH A ABS
25	to	to	pm:&gt;26	@INFMARK&gt; %AUX INFMARK&gt;
26	have	have	mod:&gt;24	@-FMAINV %VA V INF
27	a	a	det:&gt;29	@DN&gt; %&gt;N DET SG
28	profound	profound	attr:&gt;29	@A&gt; %&gt;N A ABS
29	impact	impact	obj:&gt;26	@OBJ %NH N NOM SG
30	on	on	mod:&gt;29	@&lt;NOM %N&lt; PREP
31	our	we		@&lt;P %NH PRON PERS GEN PL1
32	understanding	understand		@&lt;P-FMAINV %VA ING
33	of	of	ha:&gt;32	@ADVL %EH PREP
34	the	the	det:&gt;35	@DN&gt; %&gt;N DET
35	interplay	interplay	pcomp:&gt;33	@&lt;P %NH N NOM SG
36	between	between	mod:&gt;35	@&lt;NOM %N&lt; PREP
37	network	network	attr:&gt;38	@A&gt; %&gt;N N NOM SG
38	dynamics	dynamics	pcomp:&gt;36	@&lt;P %NH N NOM
39	and	and	cc:&gt;38	@CC %CC CC
40	social	social	attr:&gt;41	@A&gt; %&gt;N A ABS
41	evolution	evolution	cc:&gt;38	@&lt;P %NH N NOM SG
42	.     .
</fdg>
</example>
<example src="MEDLINE" no="5">
<text>
Interestingly, this reduction in liver injury failed to translate into improved survival.

</text>
       <arg n="1">improved survival
</arg>
       <arg n="2">this reduction in liver injury
</arg>
<fdg>
1	Interestingly	interestingly	meta:&gt;8	@ADVL %EH ADV
2	,	,
3	this	this	det:&gt;4	@DN&gt; %&gt;N DET DEM SG
4	reduction	reduction	subj:&gt;8	@SUBJ %NH N NOM SG
5	in	in	mod:&gt;4	@&lt;NOM %N&lt; PREP
6	liver	liver	attr:&gt;7	@A&gt; %&gt;N N NOM SG
7	injury	injury	pcomp:&gt;5	@&lt;P %NH N NOM SG
8	failed	fail	main:&gt;0	@+FMAINV %VA V PAST
9	to	to	pm:&gt;10	@INFMARK&gt; %AUX INFMARK&gt;
10	translate	translate	obj:&gt;8	@-FMAINV %VA V INF
11	into	into	goa:&gt;10	@ADVL %EH PREP
12	improved	improved	attr:&gt;13	@A&gt; %&gt;N A ABS
13	survival	survival	pcomp:&gt;11	@&lt;P %NH N NOM SG
14	.     .
</fdg>
</example>
<example src="MEDLINE" no="6">
<text>
These changes further translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation).

</text>
       <arg n="1">altered expression levels and time kinetics of a number of early genes
</arg>
       <arg n="2">These changes 
</arg>
<fdg>
1	These	this	det:&gt;2	@DN&gt; %&gt;N DET DEM PL
2	changes	change	subj:&gt;4	@SUBJ %NH N NOM PL
3	further	far	loc:&gt;4	@ADVL %EH ADV CMP
4	translate	translate	main:&gt;0	@+FMAINV %VA V PRES
5	into	into	goa:&gt;4	@ADVL %EH PREP
6	altered	altered	attr:&gt;7	@A&gt; %&gt;N A ABS
7	expression	expression	attr:&gt;8	@A&gt; %&gt;N N NOM SG
8	levels	level	pcomp:&gt;5	@&lt;P %NH N NOM PL
9	and	and	cc:&gt;8	@CC %CC CC
10	time	time	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	kinetics	kinetics	cc:&gt;8	@&lt;P %NH N NOM SG
12	of	of	mod:&gt;11	@&lt;NOM-OF %N&lt; PREP
13	a	a	det:&gt;14	@DN&gt; %&gt;N DET SG
14	number	number	pcomp:&gt;12	@&lt;P %NH N NOM
15	of	of	mod:&gt;14	@&lt;NOM-OF %N&lt; PREP
16	early	early	attr:&gt;17	@A&gt; %&gt;N A ABS
17	genes	gene	pcomp:&gt;15	@&lt;P %NH N NOM PL
18	(	(
19	peak	peak	attr:&gt;20	@A&gt; %&gt;N N NOM SG
20	expression	expression	mod:&gt;17	@NH %NH N NOM SG
21	at	at	mod:&gt;20	@&lt;NOM %N&lt; PREP
22	2	2	qn:&gt;23	@QN&gt; %&gt;N NUM CARD
23	h	h	pcomp:&gt;21	@&lt;P %NH ABBR NOM SG
24	after	after	mod:&gt;23	@&lt;NOM %N&lt; PREP
25	stimulation	stimulation	pcomp:&gt;24	@&lt;P %NH N NOM SG
26	)	)
27	.     .
</fdg>
</example>
<example src="MEDLINE" no="7">
<text>
Remarkably, differences between ligands that seem small in the [35S]GTPgammaS binding assay translate into huge differences in the magnitude of Ca2+ responses.

</text>
       <arg n="1">huge differences in the magnitude of Ca2+ responses
</arg>
       <arg n="2">differences between ligands that seem small in the [35S]GTPgammaS binding assay
</arg>
<fdg>
1	Remarkably	remarkably	meta:&gt;17	@ADVL %EH ADV
2	,	,
3	differences	difference	subj:&gt;17	@SUBJ %NH N NOM PL
4	between	between	mod:&gt;3	@&lt;NOM %N&lt; PREP
5	ligands	ligand	pcomp:&gt;4	@&lt;P %NH N NOM PL
6	that	that	subj:&gt;7	@SUBJ %NH &lt;Rel&gt; PRON
7	seem	seem	mod:&gt;5	@+FMAINV %VA V PRES
8	small	small	comp:&gt;7	@PCOMPL-S %NH A ABS
9	in	in	loc:&gt;7	@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
10	the	the	det:&gt;12	@DN&gt; %&gt;N DET
11	[	[
12	35S	35s	main:&gt;11	@NH %NH NUM CARD
13	]	]
14	GTPgammaS	gtpgammas		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@APP %NH N NOM SG	@&lt;P %NH N NOM SG
15	binding	bind		@-FMAINV %VA ING
16	assay	assay	obj:&gt;15	@OBJ %NH N NOM SG
17	translate	translate	main:&gt;0	@+FMAINV %VA V PRES
18	into	into	goa:&gt;17	@ADVL %EH PREP
19	huge	huge	attr:&gt;20	@A&gt; %&gt;N A ABS
20	differences	difference	pcomp:&gt;18	@&lt;P %NH N NOM PL
21	in	in	mod:&gt;20	@&lt;NOM %N&lt; PREP
22	the	the	det:&gt;23	@DN&gt; %&gt;N DET
23	magnitude	magnitude	pcomp:&gt;21	@&lt;P %NH N NOM SG
24	of	of	mod:&gt;23	@&lt;NOM-OF %N&lt; PREP
25	Ca2	ca2	pcomp:&gt;24	@&lt;P %NH N NOM SG
26	+	+	cc:&gt;25	@CC %CC CC
27	responses	response	cc:&gt;25	@&lt;P %NH N NOM PL
28	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
